Lord, Abbett & Co
MRK icon

Lord, Abbett & Co’s Merck MRK Stock Holding History

Lord, Abbett & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-442,414
Closed -$44M – 568
2024
Q4 		$44M Buy
442,414
+52,061
+13% +$5.37M 0.14% 189
2024
Q3 		$44.3M Buy
390,353
+218,980
+128% +$26M 0.14% 194
2024
Q2 		$21.2M Buy
+171,373
New +$22.1M 0.07% 322
2023
Q4 		– Sell
-2,991
Closed -$308K – 557
2023
Q3 		$308K Hold
2,991
– – ﹤0.01% 525
2023
Q2 		$345K Buy
2,991
+749
+33% +$85K ﹤0.01% 532
2023
Q1 		$239K Sell
2,242
-681
-23% -$73.5K ﹤0.01% 534
2022
Q4 		$324K Buy
+2,923
New +$299K ﹤0.01% 564
2021
Q2 		– Sell
-488,183
Closed -$35.9M – 679
2021
Q1 		$35.9M Sell
488,183
-1,220,705
-71% -$90M 0.09% 320
2020
Q4 		$133M Sell
1,708,888
-836,733
-33% -$64M 0.35% 78
2020
Q3 		$201M Buy
2,545,621
+41,395
+2% +$3.24M 0.64% 19
2020
Q2 		$185M Sell
2,504,226
-94,067
-4% -$7.08M 0.65% 16
2020
Q1 		$191M Buy
2,598,293
+692,921
+36% +$54.5M 0.85% 7
2019
Q4 		$165M Sell
1,905,372
-96,211
-5% -$7.9M 0.55% 25
2019
Q3 		$161M Sell
2,001,583
-616,945
-24% -$49.4M 0.55% 24
2019
Q2 		$210M Sell
2,618,528
-1,008,729
-28% -$77.2M 0.68% 9
2019
Q1 		$288M Sell
3,627,257
-837,885
-19% -$62.7M 0.96% 5
2018
Q4 		$326M Buy
4,465,142
+556,391
+14% +$39.3M 1.19% 3
2018
Q3 		$265M Buy
3,908,751
+45,737
+1% +$2.91M 0.73% 11
2018
Q2 		$224M Buy
3,863,014
+2,482,903
+180% +$140M 0.65% 13
2018
Q1 		$71.7M Sell
1,380,111
-142,493
-9% -$7.7M 0.21% 135
2017
Q4 		$81.8M Sell
1,522,604
-1,028,764
-40% -$57M 0.23% 118
2017
Q3 		$156M Buy
2,551,368
+100,841
+4% +$6.11M 0.46% 28
2017
Q2 		$150M Buy
2,450,527
+274,155
+13% +$16.7M 0.45% 34
2017
Q1 		$132M Buy
2,176,372
+981,905
+82% +$59.6M 0.39% 46
2016
Q4 		$67.1M Sell
1,194,467
-51,081
-4% -$2.99M 0.2% 147
2016
Q3 		$74.2M Buy
1,245,548
+253,197
+26% +$14.8M 0.23% 127
2016
Q2 		$54.6M Buy
992,351
+250,548
+34% +$13.3M 0.17% 180
2016
Q1 		$37.5M Sell
741,803
-3,145,491
-81% -$154M 0.12% 267
2015
Q4 		$196M Buy
3,887,294
+931,223
+32% +$47M 0.59% 19
2015
Q3 		$139M Buy
2,956,071
+2,328,738
+371% +$124M 0.42% 35
2015
Q2 		$34.1M Buy
627,333
+241,355
+63% +$13.5M 0.09% 354
2015
Q1 		$21.2M Buy
+385,978
New +$21.9M 0.05% 473
2014
Q4 		– Sell
-304,745
Closed -$17.2M – 958
2014
Q3 		$17.2M Sell
304,745
-218,369
-42% -$12.3M 0.04% 526
2014
Q2 		$28.9M Sell
523,114
-121,707
-19% -$6.64M 0.07% 426
2014
Q1 		$34.9M Sell
644,821
-627,153
-49% -$32.5M 0.08% 372
2013
Q4 		$60.7M Buy
1,271,974
+129,902
+11% +$5.94M 0.14% 214
2013
Q3 		$51.4M Sell
1,142,072
-1,175,654
-51% -$53.7M 0.12% 245
2013
Q2 		$103M Buy
+2,317,726
New +$104M 0.24% 108

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lord, Abbett & Co's MRK Position: Q1 2025 in Review

Lord, Abbett & Co sold out of Merck (MRK) in Q1 2025, closing a stake of 442,414 shares — an estimated $44M sold.

Lord, Abbett & Co first reported a position in MRK in Q2 2013 and held it in 38 quarters. The position peaked at $326M in Q4 2018. 3,448 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Lord, Abbett & Co reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Lord, Abbett & Co sold 442,414 Merck shares in Q1 2025, an estimated $44M.
  • Lord, Abbett & Co first reported a position in Merck in Q2 2013 and held it in 38 quarters.
  • Lord, Abbett & Co's Merck position peaked at $326M in Q4 2018.
  • 3,448 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Lord, Abbett & Co's 13F filing for Q1 2025, filed 13 May 2025.